Showing results (2831-2840 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|November 24, 2007
Posaconazole: an extended-spectrum triazole antifungal agentDaryl S Schiller, Horatio B FungClinical Therapeutics|November 24, 2007
Nelarabine: a novel purine antimetabolite antineoplastic agentLarry W Buie, Stacy S Epstein, Celeste M LindleyClinical Therapeutics|November 24, 2007
A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapyJaime A Davidson, Stephen O McMorn, Brian R Waterhouse, et al.Clinical Therapeutics|November 24, 2007
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 yearsJames C Kisicki, Kimberly Fiske, Andrew LyneClinical Therapeutics|November 24, 2007
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy studyGeorgios Chamilos, Mario Luna, Russell E Lewis, et al.Clinical Therapeutics|November 24, 2007
Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trialsKarl Winkler, Claudia B Ablethauser, Claudio Gimpelewicz, et al.Clinical Therapeutics|November 24, 2007
Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: an open-label, single- and multiple-dose studyLaura James, Philip Walson, Kathleen Lomax, et al.Clinical Therapeutics|November 24, 2007
A population-based analysis of statin utilization in British ColumbiaColette B Raymond, Steven G Morgan, Alan Katz, et al.Clinical Therapeutics|April 20, 2010
Systematic reviews of assessment measures and pharmacologic treatments for agitationScott L Zeller, Robert W RhoadesClinical Therapeutics|April 20, 2010
Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosisA John CammPageof 678